Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia

Research

Related Publications

Smolina K, Weymann D, Morgan S, Ross C, Carleton B. Association between regulatory advisories and codeine prescribing to postpartum women. Journal of the American Medical Association. 2015;313(18):1861-2.
Suter E, Misfeldt R, Mallinson S, Wilhelm A, Boakye O, Marchildon G, et al. Comparative Review of the Policy Landscape of Team-based Primary Health Care Service Delivery in Western Canada. Alberta Health Services; 2014.
Laberge M, Pang J, Walker K, Wong ST, Hogg W, Wodchis WP. QUALICOPC (Quality and Costs of Primary Care) Canada: A focus on the aspects of primary care most highly rated by current patients of primary care practices. Ottawa, ON: Canadian Foundation for Healthcare Improvement; 2014.
McGregor MJ, Abu-Laban RB, Ronald L, McGrail KM, Andrusiek D, Baumbusch J, et al. Nursing Home Characteristics Associated with Resident Transfers to Emergency Department. Canadian Journal on Aging. 2012;33(1):38-48.

Publication Topics

Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia

Title
Publication TypeJournal Article
Year of Publication2004
AuthorsMorgan SG, Agnew JD, Barer ML
JournalHealth policy (Amsterdam, Netherlands)Health Policy
Volume68
Issue3
Pages299 - 307
Date Published2004
KeywordsAged, Ambulatory Care/economics, British Columbia, Cost Control, Drug Costs/trends, Drug Prescriptions/classification/economics, Drug Utilization/economics/statistics & numerical data, Fees, Pharmaceutical/trends, Health Expenditures/statistics & numerical data/trends, Health Policy/economics, Health Services for the Aged/economics/utilization, Humans, Inflation, Economic, Insurance, Pharmaceutical Services, Investments
AbstractWe develop an analytic framework to map out the nature and relative importance of different cost-driving trends in the prescription drug market. This is used to measure prescription drug cost-drivers for the population of seniors in British Columbia during a period when they received comprehensive public drug coverage. Between 1991 and 2001, expenditures on prescription drugs for BC seniors increased from dollar 149 to 320 million. Increases in the population of seniors, and the rate at which they utilized therapies contributed under half of the total cost increase over the period. Changes in the mix of therapies and the type of product selected explained over half of the observed drug expenditure inflation. Increased generic substitution significantly reduced the price of products selected over the period.
Citation Key445